Alternative donors, particularly haploidentical donors, are safe and effective for elderly patients with adverse-risk

Wenxuan Huo1,2, Chuanhe Jiang3, Congxiao Zhang4

  • 1Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.

Blood Cancer Journal
|April 2, 2026
PubMed
Abstract

No abstract available in PubMed .